Expertise in
38
conditions

Dr. Sanjay K. Sharma

Hematology Oncology
2151 North Harbor Boulevard, Suite 2100, 
Fullerton, CA 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
38
conditions
2151 North Harbor Boulevard, Suite 2100, 
Fullerton, CA 

Overview

Sanjay Sharma is a Hematologist Oncology provider practicing medicine in Fullerton, California.

Dr. Sharma is highly rated in 38 conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Inflammatory Breast Cancer, Angiosarcoma, and Clear Cell Sarcoma.

He is actively involved in clinical research, co-authoring 73 peer reviewed articles and participating in 3 clinical trials. Dr. Sharma is currently accepting new patients.

Specialties

Hematology Oncology

Licenses

Internal Medicine in CA

Hospital Affiliations

Providence St. Jude Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

2151 North Harbor Boulevard, Suite 2100, Fullerton, CA 92835

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib in Patients With Metastatic Castration-Resistant Prostate Cancer
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib in Patients With Metastatic Castration-Resistant Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: August 07, 2026
Intervention Type: Drug
Study Drugs: Abemaciclib, Abiraterone Acetate, Prednisone
Study Phase: Phase 2/Phase 3
CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 01, 2026
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Double Blind, Multicenter, Parallel-group, Phase III Study to Evaluate Efficacy and Safety of DCVAC/PCa Versus Placebo in Men With Metastatic Castration Resistant Prostate Cancer Eligible for 1st Line Chemotherapy
A Randomized, Double Blind, Multicenter, Parallel-group, Phase III Study to Evaluate Efficacy and Safety of DCVAC/PCa Versus Placebo in Men With Metastatic Castration Resistant Prostate Cancer Eligible for 1st Line Chemotherapy
Enrollment Status: Completed
Publish Date: April 06, 2021
Intervention Type: Biological
Study Phase: Phase 3
View 2 Less Clinical Trials

73 Total Publications

State-of-the-Art Analytical Techniques for Quantifying DPP-4 Inhibitor Combinations: A Critical Review.
State-of-the-Art Analytical Techniques for Quantifying DPP-4 Inhibitor Combinations: A Critical Review.
Journal: Critical reviews in analytical chemistry
Published: June 04, 2026
Similar Doctors
Expertise in
48
conditions
Dr. David J. Park
Hematology Oncology
Expertise in
48
conditions
Dr. David J. Park
Hematology Oncology
Referral may be required
Before you request
2151 North Harbor Boulevard, Suite 2100, 
Fullerton, CA 
 (0.1 miles away)
714-446-5900
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

David Park is a Hematologist Oncology provider practicing medicine in Fullerton, California. Dr. Park is highly rated in 48 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Non-Hodgkin Lymphoma, Pleuropulmonary Blastoma, and Lung Cancer. Dr. Park is currently accepting new patients.

Expertise in
16
conditions
Dr. Yung Lyou
Hematology Oncology | Oncology
Expertise in
16
conditions
Dr. Yung Lyou
Hematology Oncology | Oncology
Referral may be required
Before you request
2151 North Harbor Boulevard, Suite 2100, 
Fullerton, CA 
 (0.1 miles away)
714-446-5900
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Yung Lyou is a Hematologist Oncology specialist and an Oncologist practicing medicine in Fullerton, California. Dr. Lyou is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, WT1-Related Wilms Tumor Syndromes, and Hormone Replacement Therapy (HRT). Dr. Lyou is currently accepting new patients.

Expertise in
35
conditions
Dr. Timothy E. Byun
Hematology Oncology
Expertise in
35
conditions
Dr. Timothy E. Byun
Hematology Oncology
Referral may be required
Before you request
1010 West La Veta Avenue, Suite 200, 
Orange, CA 
 (8.2 miles away)
714-541-6622
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Timothy Byun is a Hematologist Oncology provider practicing medicine in Orange, California. Dr. Byun is highly rated in 35 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Anal Cancer, Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, and Bone Marrow Aspiration. Dr. Byun is currently accepting new patients.

Frequently Asked Questions about Dr. Sanjay K. Sharma

How do I make an appointment with Dr. Sanjay K. Sharma?

You can book an appointment with Dr. Sanjay K. Sharma by calling their office at 714-446-5900. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Sanjay K. Sharma a top-rated expert for Paget Disease of the Breast?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Sanjay K. Sharma is classified as an Distinguished expert for Paget Disease of the Breast, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Sanjay K. Sharma specialize in?

While Dr. Sanjay K. Sharma is a Hematology Oncology, they have specific expertise in Paget Disease of the Breast, Inflammatory Breast Cancer, and Angiosarcoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.

Does Dr. Sanjay K. Sharma participate in research or clinical trials?

Yes. Dr. Sanjay K. Sharma has published 73 articles and abstracts on conditions like Paget Disease of the Breast. You can view a list of Dr. Sanjay K. Sharma's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Sanjay K. Sharma accept my insurance?

Dr. Sanjay K. Sharma accepts most major insurance plans, including Aetna and Alignment Health Plan. We recommend calling the office directly at 714-446-5900 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sharma's expertise for a condition
ConditionClose
    View All 32 Advanced Conditions
    View All 128 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile